Two China Companies to Bid in $765 Million Auction for I-Med Radiology of Australia

Two China healthcare companies -- Tonghua Golden-Horse Pharma (SHZ: 000766) and Golden Meditech Holdings (HK: 0801) -- will submit bids in the second round of an auction to acquire I-MED Radiology, an Australian diagnostics service company. The bidding is expected to top $765 million. With nearly 200 clinics across Australia , I-MED is the nation’s largest diagnostic imaging services provider with 18% of the market. In 2016, I-MED reported $467 million in sales and $77 million in EBITDA. More details.... Share this with colleagues: // //